Paper Details

  1. Home
  2. Paper Details

Felbamate add-on therapy for drug-resistant focal epilepsy.

Author: BresnahanRebecca, DongJianCheng, GengJinSong, Martin-McGillKirsty J, NiHengJian, ShiLi Li

Journal ArticleAn article published in an academic or professional journal that reports original research or scholarly analysis.
ReviewAn article that critically examines existing research on a particular topic and summarizes the current state of knowledge in the field.
Systematic ReviewA review that systematically collects, evaluates, and integrates relevant research to answer a specific research question.
Research Support, Non-U.S. Gov'tResearch funding provided by government agencies outside the United States.

Overview

This updated Cochrane Review examines the use of felbamate as an add-on therapy for epilepsy. Felbamate is a second-generation antiepileptic drug used to manage seizures that are resistant to standard treatments.
Paper Details　
Original Abstract of the Article :
This is an updated version of the Cochrane Review first published in 2011, and most recently updated in 2019. Epilepsy is a chronic and disabling neurological disorder, affecting approximately 1% of the population. Up to 30% of people with epilepsy have seizures that are resistant to currently avail...See full text at original site
Dr.Camel IconDr.Camel's Paper Summary Blogラクダ博士について

ラクダ博士は、Health Journal が論文の内容を分かりやすく解説するために作成した架空のキャラクターです。
難解な医学論文を、専門知識のない方にも理解しやすいように、噛み砕いて説明することを目指しています。

* ラクダ博士による解説は、あくまで論文の要点をまとめたものであり、原論文の完全な代替となるものではありません。詳細な内容については、必ず原論文をご参照ください。
* ラクダ博士は架空のキャラクターであり、実際の医学研究者や医療従事者とは一切関係がありません。
* 解説の内容は Health Journal が独自に解釈・作成したものであり、原論文の著者または出版社の見解を反映するものではありません。


引用元：
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9342851/

データ提供：米国国立医学図書館（NLM）

Felbamate: An Additional Weapon in the Fight Against Epilepsy

Epilepsy is a chronic neurological disorder that affects millions worldwide. For those who don't respond to standard anti-epileptic drugs, finding effective treatment options can be a daunting journey. This study explores the use of felbamate, a second-generation anti-epileptic drug, as an add-on therapy for drug-resistant focal epilepsy.

Felbamate: Promising Results for Drug-Resistant Epilepsy

The study reviewed the evidence on the effectiveness of felbamate as an add-on therapy for drug-resistant focal epilepsy. The authors found that felbamate can be a valuable option for individuals with this condition, providing additional relief from seizures. This research offers hope to those seeking alternative therapies for drug-resistant epilepsy, just as a desert traveler finds solace in a well.

Navigating Epilepsy Treatment: Seeking the Right Path

This study reminds us that finding the right treatment for epilepsy can be a journey, and that there may be multiple paths to achieving seizure control. The study highlights the importance of working closely with healthcare professionals to find the best treatment options and maximize the quality of life for those with epilepsy.

Dr.Camel's Conclusion

This study offers valuable insights into the potential benefits of felbamate as an add-on therapy for drug-resistant focal epilepsy. It underscores the importance of personalized treatment approaches for epilepsy and the continuous pursuit of effective therapies for those struggling with this challenging condition.

Date :
  1. Date Completed 2022-08-03
  2. Date Revised 2023-08-02
Further Info :

Pubmed ID

35914010

DOI: Digital Object Identifier

PMC9342851

Related Literature

Article Analysis
・Effective treatment of epilepsy
SNS
PICO Info
in preparation
Languages

English

Positive IndicatorAn AI analysis index that serves as a benchmark for how positive the results of the study are. Note that it is a benchmark and requires careful interpretation and consideration of different perspectives.

This site uses cookies. Visit our privacy policy page or click the link in any footer for more information and to change your preferences.